MedPath

Medical University of Vienna

Medical University of Vienna logo
🇦🇹Austria
Ownership
Private
Established
1365-01-01
Employees
1K
Market Cap
-
Website
http://www.meduniwien.ac.at

Rapydan Topical Anaesthesia for Arterial Cannulation

Phase 4
Completed
Conditions
Arterial Catheterization
Interventions
Drug: Placebo Patch
Drug: Lidocaine/tetracaine patch
Drug: Subcutaneous injection of 0.5 ml Lidocain 1%
Drug: Subcutaneous injection of saline
First Posted Date
2011-12-16
Last Posted Date
2013-03-18
Lead Sponsor
Medical University of Vienna
Target Recruit Count
90
Registration Number
NCT01494311
Locations
🇺🇸

Cleveland Clinic Department of Outcomes Research, Cleveland, Ohio, United States

🇦🇹

Medical University of Vienna, Vienna, Austria

🇨🇦

Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada

Evaluation of a Local Preconditioning Effect in Patients Undergoing Cardiac Surgery

Not Applicable
Terminated
Conditions
Coronary Artery Bypass Graft Triple Vessel
Heart Disease
Interventions
Device: PICSO
First Posted Date
2011-12-01
Last Posted Date
2015-04-07
Lead Sponsor
Medical University of Vienna
Target Recruit Count
5
Registration Number
NCT01482780
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders

Phase 4
Completed
Conditions
Anxiety Disorder
Major Depressive Disorder (MDD)
Interventions
First Posted Date
2011-11-22
Last Posted Date
2016-09-14
Lead Sponsor
Medical University of Vienna
Target Recruit Count
289
Registration Number
NCT01477203
Locations
🇦🇹

Medical University of Vienna, Department for Psychiatrie and Psychotherapie, Vienna, Austria

Impact of n-3 Polyunsaturated Fatty Acids in a Protein-enriched Diet With Low GI in Type 2 Diabetes Patients

Completed
Conditions
Obese
Insulin Resistance
Diabetes
Overweight
Interventions
Dietary Supplement: n-3 PUFA in protein-enriched low-GI diet
First Posted Date
2011-11-18
Last Posted Date
2016-03-16
Lead Sponsor
Medical University of Vienna
Target Recruit Count
30
Registration Number
NCT01474603
Locations
🇦🇹

Dept. Medicine III, Medical University of Vienna, Vienna, Austria

An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns

Phase 4
Completed
Conditions
Wound Healing
Scar Formation
Interventions
Device: Autologous skin
Device: Wound coverage by acellular skin substitute
First Posted Date
2011-10-19
Last Posted Date
2011-10-19
Lead Sponsor
Medical University of Vienna
Target Recruit Count
18
Registration Number
NCT01454310
Locations
🇦🇹

Medical University of Vienna, Burn Center, Department of Plastic and Reconstructive Surgery, Vienna, Austria

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

Phase 2
Completed
Conditions
Birch Pollen Related Apple Allergy
Birch Pollen Allergy
Interventions
Drug: rMal d 1
Drug: rBet v 1
Other: placebo drops
First Posted Date
2011-10-10
Last Posted Date
2017-04-13
Lead Sponsor
Medical University of Vienna
Target Recruit Count
60
Registration Number
NCT01449786
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation

Phase 4
Completed
Conditions
Atrial Fibrillation
Interventions
First Posted Date
2011-10-06
Last Posted Date
2015-05-13
Lead Sponsor
Medical University of Vienna
Target Recruit Count
101
Registration Number
NCT01447862
Locations
🇦🇹

Medical University of Vienna, Department of Emergency Medicine, Vienna, Austria

Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length

Phase 4
Completed
Conditions
Menorrhagia
First Posted Date
2011-09-20
Last Posted Date
2013-03-08
Lead Sponsor
Medical University of Vienna
Target Recruit Count
290
Registration Number
NCT01436903
Locations
🇦🇹

Landesklinikum Thermenregion Neunkirchen, Neunkirchen, Lower Austria, Austria

Non-invasive Evaluation of Fluid Status and Cardiac Output During Operative Treatment of Pheochromcytoma

Completed
Conditions
Pheochromocytoma
First Posted Date
2011-08-30
Last Posted Date
2014-02-13
Lead Sponsor
Medical University of Vienna
Target Recruit Count
15
Registration Number
NCT01425710
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

Completed
Conditions
Pneumonia
Urinary Tract Infection
Abdominal Infection
First Posted Date
2011-08-11
Last Posted Date
2017-08-29
Lead Sponsor
Medical University of Vienna
Target Recruit Count
16
Registration Number
NCT01414959
Locations
🇦🇹

Med. Univ. of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath